Dr. Tucker Dee Simmons I Pharmacist - Geriatric Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 Fax: 334-297-5223 |
Miriam Anne Jones Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5408 Summerville Rd, Phenix City, AL 36867 Phone: 334-291-8533 |
Derek Reif, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1430 Highway 280 Byp, Phenix City, AL 36867 Phone: 334-297-6498 |
Samantha Smith Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3864 Us Highway 80 W, Phenix City, AL 36870 Phone: 334-408-6068 |
Mrs. Amy M Reaves Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3952 Us Highway 80 W, Phenix City, AL 36870 Phone: 334-214-9129 Fax: 334-214-9640 |
Dr. Mark A Popwell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 Fax: 334-297-5223 |
Dr. Shannon Leigh Waldrop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5405 Summerville Rd, Phenix City, AL 36867 Phone: 334-214-4508 |
Wade Lucas Moore, PHARMD Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 3952 Us Highway 80 W, Phenix City, AL 36870 Phone: 334-214-9129 Fax: 334-214-9640 |
Tiffani Marie Fulmer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 |
Mr. Charles Arthur Cavanaugh, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 |
Cassady Sims Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5301 Summerville Rd, Phenix City, AL 36867 Phone: 334-297-3061 |
James Eugene Davis Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5301 Summerville Rd, Phenix City, AL 36867 Phone: 334-297-3061 Fax: 334-297-0193 |
Dr. William Joseph Mcfaull, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5301 Summerville Rd, Phenix City, AL 36867 Phone: 334-297-3061 |
Alexander Glass, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 |
Dr. Laura Elizabeth Perry, PHARMD, RPH Pharmacist - Geriatric Medicare: Not Enrolled in Medicare Practice Location: 5301 Summerville Rd, Phenix City, AL 36867 Phone: 334-297-3061 Fax: 334-297-0193 |
Dr. Nylvia Ware, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 |
Mrs. Barbara G Hardwick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3482 Crosswind Dr, Phenix City, AL 36869 Phone: 334-500-4695 Fax: 334-352-3317 |
Debbie Watford Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Highway 280 Byp, Phenix City, AL 36867 Phone: 334-291-3076 |
Jennifer Rammage Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 2515 Crawford Rd, Phenix City, AL 36867 Phone: 334-297-3722 |
Stacy C Benoit, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1810 Stadium Dr, Suite 100, Phenix City, AL 36867 Phone: 334-291-4257 Fax: 334-291-4251 |
News Archive
Epigenetic therapy with histone deacetylase inhibitors is worth pursuing in hormone receptor positive advanced breast cancer, suggests a phase III trial reported today at the ESMO 2018 Congress in Munich.
Despite lowering low-density lipoprotein (LDL), known as "bad" cholesterol, while markedly increasing levels of high-density lipoprotein (HDL), or "good" cholesterol, a large clinical trial to investigate the cholesterol drug evacetrapib was discontinued early after a preliminary analysis showed it did not reduce rates of major adverse cardiovascular events, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.
The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug's target, according to clinical trial results from The University of Texas MD Anderson Cancer Center.
In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co-administered with atorvastatin, there were persistent lipid effects in the higher dose arms in both the monotherapy and co-administration treatment groups eight weeks after stopping active therapy with anacetrapib.
In a promising development for cancer patients in the New York metropolitan area, the Long Island Jewish (LIJ) Medical Center Department of Radiation Medicine announced today that it will acquire an innovative new system called TrueBeam that offers a radically different approach to treating cancer with image-guided radiotherapy.
› Verified 9 days ago